Vaxil BioTherapeutics To Present At BIO CEO & Investor Conference February 13 – 14, 2017 Post author:Sam Post published:February 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like New FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices May 15, 2017 WuXi AppTec Lab Testing Division's Analytical And Stability Testing Facilities Passed FDA Inspection April 11, 2016 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
WuXi AppTec Lab Testing Division's Analytical And Stability Testing Facilities Passed FDA Inspection April 11, 2016
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017